Cart
sales@molnova.com
Cefuzonam
CAS No. 82219-78-1
Cefuzonam( —— )
Catalog No. M36124 CAS No. 82219-78-1
Cefuzonam is a novel cephalosporin with anti-inflammatory and antibacterial activity that can be used in studies of respiratory tract infections, tonsillitis, and hepatobiliary infections.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 25MG | 1444 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCefuzonam
-
NoteResearch use only, not for human use.
-
Brief DescriptionCefuzonam is a novel cephalosporin with anti-inflammatory and antibacterial activity that can be used in studies of respiratory tract infections, tonsillitis, and hepatobiliary infections.
-
DescriptionCefuzonam is a novel cephalosporin with anti-inflammatory and antibacterial activity that can be used in studies of respiratory tract infections, tonsillitis, and hepatobiliary infections.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
RecptorAntibiotic
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82219-78-1
-
Formula Weight513.59
-
Molecular FormulaC16H15N7O5S4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(O)(=O)C=1N2[C@@]([C@H](NC(/C(=N\OC)/C3=CSC(N)=N3)=O)C2=O)(SCC1CSC4=CN=NS4)[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Neomycin Sulphate B
Neomycin belongs to aminoglycoside class of antibiotics that contain two or more aminosugars connected by glycosidic bonds.
-
3-CPs
3-CPs (3-Carbethoxypsoralen) is a bleomycin-induced serotypic podoplanar polysaccharide in mouse lung fibrosis that belongs to the psoralen family and interferes with antibody-mediated bacterial killing.
-
Moxipraquine
Moxipraquine is a novel 8-aminoquinolone compound with anti-infective activity against Trypanosoma cruzi. Moxipraquine effectively inhibited parasitemia but did not eradicate infections in mice or guinea pigs.
